liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management
Linköping University, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Medicine Center, Department of Infectious Diseases.ORCID iD: 0000-0002-5290-5165
Linköping University, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection. Linköping University, Faculty of Medicine and Health Sciences.ORCID iD: 0000-0003-1784-2864
Linköping University, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection. Linköping University, Faculty of Medicine and Health Sciences.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Medicine Center, Department of Infectious Diseases.
Show others and affiliations
2026 (English)In: Clinical Infectious Diseases, ISSN 1058-4838, E-ISSN 1537-6591, Vol. 82, no 5, p. e1045-e1052, article id PMID 9203213Article, review/survey (Refereed) Published
Abstract [en]

Developing shorter treatment regimens for tuberculosis requires careful characterization of the clinical phenotype, which is defined by patient characteristics, radiological extent of disease, mycobacterial burden, drug susceptibility, and host response. Advances in 'omics and model-informed precision dosing, as well as integrated algorithms using artificial intelligence, need to be adapted and validated in clinical trials to improve classification of patients for stratified treatment. When treatment is initiated based on the clinical phenotype, monitoring of treatment response can be improved by quantification of bacterial load, transcriptomic and epigenetic biosignatures for sputum-free monitoring, and assessing disease burden by radiological and symptom scoring tools. Many of these tools are suitable for high-endemic settings. Such integrated monitoring allows prompt drug adjustments for rapid reduction in bacterial load, which prevents development of drug resistance and achieves relapse-free cure even with shorter treatment. This review explores current and future tools for defining and managing clinical tuberculosis phenotypes from a clinical perspective. Treatment monitoring using bacterial quantification and 'omics with model-informed precision dosing may reduce relapse and improve patient selection for stratified shorter regimens.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS INC , 2026. Vol. 82, no 5, p. e1045-e1052, article id PMID 9203213
Keywords [en]
tuberculosis; precision medicine; treatment monitoring; stratified treatment; disease severity
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:liu:diva-220754DOI: 10.1093/cid/ciaf663ISI: 001661560100001PubMedID: 41537599Scopus ID: 2-s2.0-105039464175OAI: oai:DiVA.org:liu-220754DiVA, id: diva2:2032882
Note

Funding Agencies|Swedish Research Council [2019-05912, 2022-05263, 2022-00865, 2022-04041]; Swedish Heart-Lung Foundation [2022-0238, 2022-0148]; Region Ostergoetland, Sweden [ALF 987589, ROE-1005642]; Veni project [09150161910052]; Dutch Research Council (NWO)

Available from: 2026-01-28 Created: 2026-01-28 Last updated: 2026-10-13Bibliographically approved

Open Access in DiVA

fulltext(631 kB)52 downloads
File information
File name FULLTEXT01.pdfFile size 631 kBChecksum SHA-512
51197cbb08fcd9f5a6895fd219a1251245492d9ba9bab543c7ce7beedeb86a05e327c907d557efd1db5f969d9422d94bb789919eca8473386f8b15fb826e5d11
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Niward, KatarinaBraian, ClaraSvärdhagen, GustavAugustinsson, DanielÖhrnberg, IsabelleSchön, Thomas

Search in DiVA

By author/editor
Niward, KatarinaBraian, ClaraSvärdhagen, GustavAugustinsson, DanielÖhrnberg, IsabelleSchön, Thomas
By organisation
Division of Inflammation and InfectionFaculty of Medicine and Health SciencesDepartment of Infectious DiseasesDepartment of Clinical Microbiology
In the same journal
Clinical Infectious Diseases
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 52 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 55 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf